May 16, 2023

Amy Dockser Marcus, Author of "We the Scientists" (part 1)

Amy Dockser Marcus, Author of "We the Scientists" (part 1)

About This Episode

We the Scientists: How a Daring Team of Parents and Doctors Forged A New Path for Medicine

Pulitzer Prize winning Wall Street Reporter Amy Marcus, in her new book We the Scientists, discusses a rare disease often likened to Children’s Alzheimer’s with BrainStorm host, Meryl Comer. Not only are the patients young, but their parents are desperate to help scientists find a drug to slow disease progression to extend their lives. Most children, born seemingly normal, rarely live beyond the age of 20. The common thread is advancing the science with new pathways for treating disease and conducting research. In the process to accelerate new drug development, science may be forever changed.

This episode of BrainStorm is sponsored by Genentech and Eisai.

For more information about this episode and a search to cure Alzheimer's go to UsAgainstAlzheimers.org

BrainStorm Feed

100

2025 Year in Review and Predictions for 2026 with George Vradenburg

George Vradenburg, Chairman and Founder of UsAgainstAlzheimer's, sits down with host Meryl Comer for a comprehensive look at the state of Alzheimer's research, advocacy, and care in 2025.
LISTEN NOW
99

The Future of Alzheimer's Trials: AI, Biomarkers, and Remote Research – John Dwyer, CEO of The Global Alzheimer’s Platform (part 2)

In part 2 John Dwyer, CEO of the Global Alzheimer's Platform (GAP), and BrainStorm host Meryl Comer discuss transforming Alzheimer's research and clinical trials.
LISTEN NOW
98

The Future of Alzheimer's Trials: Bringing Cutting-Edge Research to Every Community - John Dwyer, CEO of The Global Alzheimer's Platform

John Dwyer, CEO of the Global Alzheimer's Platform (GAP), highlights GAP's innovations in improving the participant experience through streamlining visits, personalized feedback, and bringing mobile trials directly to small communities.
LISTEN NOW